Scpharmaceuticals Stock Price on November 29, 2024
| SCPH Stock | USD 3.62 0.12 3.21% |
Below is the normalized historical share price chart for Scpharmaceuticals extending back to November 17, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Scpharmaceuticals stands at 3.62, as last reported on the 30th of November, with the highest price reaching 3.80 and the lowest price hitting 3.57 during the day.
If you're considering investing in Scpharmaceuticals Stock, it is important to understand the factors that can impact its price. Scpharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.12, which indicates the firm had a -0.12% return per unit of risk over the last 3 months. Scpharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Scpharmaceuticals' Variance of 13.31, risk adjusted performance of (0.08), and Coefficient Of Variation of (920.20) to confirm the risk estimate we provide.
As of now, Scpharmaceuticals' Stock Based Compensation is increasing as compared to previous years. . As of now, Scpharmaceuticals' Price Book Value Ratio is increasing as compared to previous years. The Scpharmaceuticals' current Price To Book Ratio is estimated to increase to 6.81, while Price To Sales Ratio is projected to decrease to 14.22. Scpharmaceuticals Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 17th of November 2017 | 200 Day MA 4.6459 | 50 Day MA 4.1646 | Beta 0.14 |
Scpharmaceuticals |
Sharpe Ratio = -0.1151
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SCPH |
Estimated Market Risk
| 3.7 actual daily | 32 68% of assets are more volatile |
Expected Return
| -0.43 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Scpharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Scpharmaceuticals by adding Scpharmaceuticals to a well-diversified portfolio.
Price Book 6.0943 | Enterprise Value Ebitda (6.69) | Price Sales 5.9827 | Shares Float 21.2 M | Wall Street Target Price 18 |
Related Headline
Seres Therapeutics Headline on 29th of November 2024
Providence Wealth Advisors LLC Grows Stock Position in Seres... by thelincolnianonline.com
Providence Wealth Advisors LLC grew its position in Seres Therapeutics, Inc. by 29.2 percent during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission . The institutional investor owned 98,500 shares of the biotechnology companys stock after acquiring an additional 22,250 shares during
Scpharmaceuticals Valuation on November 29, 2024
It is possible to determine the worth of Scpharmaceuticals on a given historical date. On November 29, 2024 Scpharmaceuticals was worth 3.77 at the beginning of the trading date compared to the closed value of 3.62. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Scpharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Scpharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Scpharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Scpharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 3.62 | 3.82 | 3.55 | 3.74 | 348,581 | |
11/29/2024 | 3.77 | 3.80 | 3.57 | 3.62 | 204,746 |
| Backtest Scpharmaceuticals | | | Scpharmaceuticals History | | | Scpharmaceuticals Valuation | Previous |
Scpharmaceuticals Trading Date Momentum on November 29, 2024
| On November 29 2024 Scpharmaceuticals was traded for 3.62 at the closing time. The top price for the day was 3.80 and the lowest listed price was 3.57 . The trading volume for the day was 204.7 K. The trading history from November 29, 2024 did not result in any price rise and fall. The trading price change against the current closing price is 4.14% . |
Scpharmaceuticals Fundamentals Correlations and Trends
By evaluating Scpharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Scpharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Scpharmaceuticals financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Scpharmaceuticals Stock history
Scpharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Scpharmaceuticals is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Scpharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Scpharmaceuticals stock prices may prove useful in developing a viable investing in Scpharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 38.5 M | 22.2 M | |
| Net Loss | -33.2 M | -34.8 M |
Scpharmaceuticals Quarterly Net Working Capital |
|
Scpharmaceuticals Stock Technical Analysis
Scpharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Scpharmaceuticals Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Scpharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Scpharmaceuticals November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Scpharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Scpharmaceuticals shares will generate the highest return on investment. By undertsting and applying Scpharmaceuticals stock market strength indicators, traders can identify Scpharmaceuticals entry and exit signals to maximize returns
Scpharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Scpharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Scpharmaceuticals Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Scpharmaceuticals to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.62) | |||
| Total Risk Alpha | (1.02) | |||
| Treynor Ratio | (0.24) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Scpharmaceuticals Stock analysis
When running Scpharmaceuticals' price analysis, check to measure Scpharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scpharmaceuticals is operating at the current time. Most of Scpharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Scpharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scpharmaceuticals' price. Additionally, you may evaluate how the addition of Scpharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |